Which Score for What? Operationalizing Standardized Cognitive Test Performance for the Assessment of Change [0.03%]
该怎样评分？对标准化认知测试表现的量化以评估变化情况
Cristan Farmer,Audrey Thurm,Tanvi Das et al.
Cristan Farmer et al.
Developmental domains, such as cognitive, language, and motor, are key concepts of interest in longitudinal studies of intellectual and developmental disabilities (IDD). Normative scores (e.g., IQ) are often used to operationalize performan...
Genetic Subtypes of Phelan-McDermid Syndrome Exhibit Similar Rates of Change Despite Differences in Level of Impairment in Developmental Constructs [0.03%]
不同类型的Phelan-McDermid综合征在发育构念的水平上存在差异但发展速率相似
Tess Levy,Cristan Farmer,Siddharth Srivastava et al.
Tess Levy et al.
The clinical spectrum of Phelan-McDermid syndrome (PMS) is varied, with wide-ranging degrees of intellectual disability, developmental delays, behavioral abnormalities, and medical features. Different types of genetic variation lead to PMS,...
Retrospective Reports of Skill Attainment and Loss in Phelan-McDermid Syndrome [0.03%]
菲伦-麦德玛综合征技能获得和丧失的回顾性报告
Cristan Farmer,Ivy Giserman-Kiss,Ellora Mohanty et al.
Cristan Farmer et al.
Phelan-McDermid syndrome (PMS) is a genetic condition associated with profound neurodevelopmental disabilities. This study described patterns of onset and loss of developmental milestones and associated skills using questionnaire data from ...
Characterizing Developmental and Behavioral Profiles in Developmental Synaptopathies to Inform Clinical Trial Endpoints [0.03%]
描绘发育性突触病的发育和行为特征以确定临床试验终点指标
Latha Valluripalli Soorya,Camille W Brune,Cristan A Farmer et al.
Latha Valluripalli Soorya et al.
The Developmental Synaptopathies Consortium is a multisite natural history network studying rare, neurogenetic syndromes associated with synaptic dysfunction and developmental delays. One aim of the Consortium is clinical trial readiness, i...
Longitudinal Trajectory of Adaptive Skills in Phelan-McDermid Syndrome [0.03%]
费兰-德默德综合症患者的适应行为纵向轨迹研究
Siddharth Srivastava,Kristina Johnson,Cristan Farmer et al.
Siddharth Srivastava et al.
Phelan-McDermid syndrome (PMS), caused by SHANK3 haploinsufficiency, lacks natural history data. We report the trajectory of adaptive behavior from a prospective, longitudinal, natural history study. English-speaking people aged 3-21 years ...
Introduction to the Special Issue on Phenotypic Explorations of Phelan McDermid Syndrome and Other Developmental Synaptopathies [0.03%]
普林麦德逊综合征和其他发育性突触病表型探索专题介绍
Frank J Symons
Frank J Symons
A Transdiagnostic Comparison of Mindfulness and Parenting Stress in Mothers of Children With Autism, Developmental Delay, and Fragile X Syndrome [0.03%]
一类与自闭症、发育迟缓和脆性X综合症患儿母亲正念和父母压力的跨诊断比较
Laurel R Benjamin,Cameron L Neece,Laura Lee McIntyre et al.
Laurel R Benjamin et al.
This study compared mindfulness and parenting daily hassles (PDH) among mothers of children with autism spectrum disorder (ASD), developmental delay (DD), and Fragile X syndrome (FXS), and explored diagnostic group as a moderator of the rel...
Attitudes, Assumptions, and Beliefs of Obstetric Care Clinicians Regarding Perinatal Care of Women With Intellectual and Developmental Disabilities [0.03%]
obstetric临床医生对智力障碍和发育障碍女性围产期护理的态度、假设和信念
Lauren D Smith,Robyn M Powell,Aishwarya Khanna et al.
Lauren D Smith et al.
This study examines clinician attitudes, beliefs, and assumptions regarding perinatal care of women with intellectual and developmental disabilities (IDD) from the perspectives of both clinicians and women with IDD. We conducted semistructu...
Individual and Environmental Factors Associated With Polypsychotropic Medication Regimens Among Adults With Intellectual Disability [0.03%]
智力残疾成年人多心理药物治疗的相关个体及环境因素分析
Kami L Gallus,Jennifer L Jones,Steven R Erickson
Kami L Gallus
Polypharmacy, the concurrent use of multiple medications, is common among adults with intellectual disability. Psychotropic medications are often implicated in polypharmacy among this population. The current study aimed to determine individ...